Many children with autism, ADHD, epilepsy, or Tuberous Sclerosis Complex struggle with sensory overload. They feel overwhelmed by sounds, lights, or textures, which often leads to anxiety, poor sleep, and fatigue. A recent trial looked at whether a common diuretic called bumetanide could help these specific struggles in kids aged seven to 19.
The study involved 113 children who took bumetanide for up to six months. Researchers tracked their feelings using a special set of questions that measure anxiety, depression, sleep quality, and how well they get along with peers. They found that at the start, most kids scored very low on these measures, showing significant trouble in these areas.
During the trial, 83 percent of the children showed improvement in at least one area. Specifically, 41 percent felt less anxious and 38 percent felt less depressed. The treatment also helped with sleep and energy levels. These improvements were linked to how much sensory overload each child experienced.
While the results look promising, the study design did not fully hide which children were taking the medicine. This means we cannot be 100 percent sure the drug caused every single improvement. However, the findings suggest that bumetanide might be a useful option for doctors considering for kids with these complex needs.
